SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-17-000317
Filing Date
2017-03-16
Accepted
2017-03-16 16:01:52
Documents
5
Period of Report
2017-03-10
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT f8k031517_8k.htm 8-K 13191
2 EXHIBIT 99.1 PRESS RELEASE f8k031517_ex99z1.htm EX-99.1 18859
3 EXHIBIT 99.2 TRANSCRIPT OF CONFERENCE CALL f8k031517_ex99z2.htm EX-99.2 68707
4 IMAGE f8k031517_ex99z2002.jpg GRAPHIC 700363
5 IMAGE f8k031517_ex99z2003.jpg GRAPHIC 93928
  Complete submission text file 0001078782-17-000317.txt   1195189
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 17694435
SIC: 2835 In Vitro & In Vivo Diagnostic Substances